CG
MRNA icon

Cutler Group’s Moderna MRNA Stock Holding History

Cutler Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,500
Closed -$40K – 3111
2023
Q4 		$40K Sell
14,500
-9,000
-38% -$757K ﹤0.01% 1578
2023
Q3 		$207K Buy
23,500
+11,300
+93% +$1.26M 0.02% 735
2023
Q2 		$316K Sell
12,200
-42,300
-78% -$5.64M 0.04% 461
2023
Q1 		$522K Sell
54,500
-93,200
-63% -$15.4M 0.05% 342
2022
Q4 		$1.17M Buy
147,700
+42,400
+40% +$6.93M 0.1% 211
2022
Q3 		$3.33M Buy
105,300
+4,400
+4% +$668K 0.23% 78
2022
Q2 		$2.33M Sell
100,900
-48,900
-33% -$6.99M 0.16% 137
2022
Q1 		$3.3M Buy
149,800
+119,200
+390% +$20.1M 0.17% 119
2021
Q4 		$859K Buy
30,600
+27,300
+827% +$7.98M 0.04% 510
2021
Q3 		$10K Buy
+3,300
New +$1.22M ﹤0.01% 3939
2021
Q2 		– Sell
-500
Closed -$2K – 6108
2021
Q1 		$2K Sell
500
-18,300
-97% -$2.65M ﹤0.01% 4967
2020
Q4 		$277K Buy
18,800
+6,900
+58% +$698K 0.01% 907
2020
Q3 		$17K Buy
11,900
+2,600
+28% +$181K ﹤0.01% 2580
2020
Q2 		$29K Sell
9,300
-4,400
-32% -$241K ﹤0.01% 2121
2020
Q1 		$50K Buy
13,700
+9,700
+243% +$223K ﹤0.01% 1716
2019
Q4 		$10K Hold
4,000
– – ﹤0.01% 2645
2019
Q3 		$23K Buy
4,000
+3,000
+300% +$44.3K ﹤0.01% 2087
2019
Q2 		$5K Buy
+1,000
New +$21.5K ﹤0.01% 3115

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cutler Group's MRNA Position: Q1 2024 in Review

Cutler Group increased its Moderna (MRNA) stake by 160% in Q1 2024, buying an estimated $8.06K and bringing the position to 130 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #1186.

Cutler Group first reported a position in MRNA in Q4 2018 and has held it in 20 quarters since. The position peaked at $11.5M in Q1 2022. 902 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • Cutler Group held 130 shares of Moderna worth $13K as of Q1 2024.
  • Cutler Group bought 80 Moderna shares in Q1 2024, an estimated $8.06K.
  • Moderna made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1186 holding.
  • Cutler Group first reported a position in Moderna in Q4 2018 and has held it in 20 quarters since.
  • Cutler Group's Moderna position peaked at $11.5M in Q1 2022.
  • 902 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.